Skip to Main Content

Print | Bookmark | | Font Size: + |

July 7, 2023

Broader Medicare Coverage of Leqembi Available Following FDA Traditional Approval

Broader Medicare coverage is now available for Biogen and Eisai's Leqembi (the brand name for lecanemab) following the Food and Drug Administration's (FDA) move to grant traditional approval to the drug that treats individuals with Alzheimer's disease. The Centers for Medicare & Medicaid Services had previously announced this would be the case and released more details on coverageExternal Website.

26 Century Blvd Ste ST610, Nashville, TN 37214-3685 © CGS Administrators, LLC. All Rights Reserved